AAAAAA

   
Results: 1-15 |
Results: 15
Amifostine alone and in combination with erythropoietin for the treatment of favorable myelodysplastic syndrome
Authors: Tefferi, A Elliott, MA Steensma, DP Hook, CC Dispenzieria, A Hanson, CA Schroeder, G Letendre, L
Citation: A. Tefferi et al., Amifostine alone and in combination with erythropoietin for the treatment of favorable myelodysplastic syndrome, LEUK RES, 25(2), 2001, pp. 183-185
Myelodysplasia with fibrosis: a distinct entity?
Authors: Steensma, DP Hanson, CA Letendre, L Tefferi, A
Citation: Dp. Steensma et al., Myelodysplasia with fibrosis: a distinct entity?, LEUK RES, 25(10), 2001, pp. 829-838
Hereditary red blood cell disorders in Middle Eastern patients
Authors: Steensma, DP Hoyer, JD Fairbanks, VF
Citation: Dp. Steensma et al., Hereditary red blood cell disorders in Middle Eastern patients, MAYO CLIN P, 76(3), 2001, pp. 285-293
A high bone marrow plasma cell labeling index in stable plateau-phase multiple myeloma is a marker for early disease progression and death
Authors: Steensma, DP Gertz, MA Greipp, PR Kyle, RA Lacy, MQ Lust, JA Offord, JR Plevak, MF Therneau, TM Witzig, TE
Citation: Dp. Steensma et al., A high bone marrow plasma cell labeling index in stable plateau-phase multiple myeloma is a marker for early disease progression and death, BLOOD, 97(8), 2001, pp. 2522-2523
Clarifications to the standard neutrophil response criteria for clinical trials in myelodysplastic syndromes are needed
Authors: Steensma, DP Letendre, L Tefferi, A
Citation: Dp. Steensma et al., Clarifications to the standard neutrophil response criteria for clinical trials in myelodysplastic syndromes are needed, BLOOD, 97(10), 2001, pp. 3321-3322
"Congo" red - Out of Africa
Authors: Steensma, DP
Citation: Dp. Steensma, "Congo" red - Out of Africa, ARCH PATH L, 125(2), 2001, pp. 250-252
The art and science of prognosis in patients with advanced cancer
Authors: Steensma, DP Loprinzi, CL
Citation: Dp. Steensma et Cl. Loprinzi, The art and science of prognosis in patients with advanced cancer, EUR J CANC, 36(16), 2000, pp. 2025-2027
The narrow path
Authors: Steensma, DP
Citation: Dp. Steensma, The narrow path, J CL ONCOL, 19(7), 2000, pp. 2102-2105
Submitting to autonomy
Authors: Steensma, DP
Citation: Dp. Steensma, Submitting to autonomy, J CL ONCOL, 18(21), 2000, pp. 3736-3737
Autoimmune hemolytic anemia in a patient with autosomal dominant chronic mucocutaneous candidiasis
Authors: Steensma, DP Tefferi, A Weiler, CR
Citation: Dp. Steensma et al., Autoimmune hemolytic anemia in a patient with autosomal dominant chronic mucocutaneous candidiasis, MAYO CLIN P, 75(8), 2000, pp. 853-855
Lymphadenopathy
Authors: Habermann, TM Steensma, DP
Citation: Tm. Habermann et Dp. Steensma, Lymphadenopathy, MAYO CLIN P, 75(7), 2000, pp. 723-732
Sister (Mary) Joseph's nodule
Authors: Steensma, DP
Citation: Dp. Steensma, Sister (Mary) Joseph's nodule, ANN INT MED, 133(3), 2000, pp. 237-237
Littoral cell angioma associated with portal hypertension and resected colon cancer
Authors: Steensma, DP Morice, WG
Citation: Dp. Steensma et Wg. Morice, Littoral cell angioma associated with portal hypertension and resected colon cancer, ACT HAEMAT, 104(2-3), 2000, pp. 131-134
Fifty years of Tart cells
Authors: Steensma, DP
Citation: Dp. Steensma, Fifty years of Tart cells, MAYO CLIN P, 74(9), 1999, pp. 936-938
Elevated serum LDH in patients with non-Hodgkin's lymphoma: Not always an ominous sign
Authors: Steensma, DP Witzig, TE
Citation: Dp. Steensma et Te. Witzig, Elevated serum LDH in patients with non-Hodgkin's lymphoma: Not always an ominous sign, BR J HAEM, 107(2), 1999, pp. 463-464
Risultati: 1-15 |